The Roles of Tissue Factor in Malignant Gliomas

N/ACompletedNCT00201903

Ontario Clinical Oncology Group (OCOG)30 enrolled

Overview

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

Study Type

OBSERVATIONAL

Enrollment

Conditions

Venous Thromboembolism Brain Tumors

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * participation in PRODIGE * adult patients * newly diagnosed, biopsy-confirmed grade III/IV malignant gliomas * undergone craniotomy or stereotactic biopsy \> 2 days and \< 4 weeks before Exclusion Criteria: * have known hereditary thrombophilia * are receiving experimental antiangiogenic therapy

Locations (6)

Henry Ford Hospital

Detroit, Michigan, United States

Huntsman Cancer Institute

Salt Lake City, Utah, United States

Cross Cancer Institute

Edmonton, Alberta, Canada

CancerCare Manitoba

Winnipeg, Manitoba, Canada

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.